Concord Drugs standalone net profit rises 475.00% in the September 2021 quarter
Sales decline 40.68% to Rs 9.83 crore
Net profit of Concord Drugs rose 475.00% to Rs 0.46 crore in the quarter ended September 2021 as against Rs 0.08 crore during the previous quarter ended September 2020. Sales declined 40.68% to Rs 9.83 crore in the quarter ended September 2021 as against Rs 16.57 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales9.8316.57 -41 OPM %16.795.37 -PBDT1.370.44 211 PBT0.800.11 627 NP0.460.08 475Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 19 2021 | 8:00 AM IST